In summary, to the authors’ knowledge, our report is the first to evaluate the diagnostic usefulness of MMP-7 and TIMP-1 independently and, especially, in combination with both established ovarian tumor markers. This evidence concerns the gene TIMP1 and ovarian neoplasm.